Silver Book Fact

Glycoprotein inhibitors have been shown to reduce the risk of death, a second heart attack, or the need for revascularization by 48% to 52% in patients who have suffered a first heart attack.

MEDTAP International, Inc. The Value of Investment in Health Care: Better care, better lives. Bethesda, MD: MEDTAP; 2004. http://www.aha.org/content/00-10/08affordability-value.pdf

Reference

Title
The Value of Investment in Health Care: Better care, better lives
Publisher
MEDTAP
Publication Date
2004
Authors
MEDTAP International, Inc
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Death Rates for Coronary Heart Disease, 1950-1998  
  • Hospitalization from incorrect diagnosis of heart attacks costs $12 billion per year. If creatine kinase, myoglobin and troponin are used for detecting heart attack in ER patients with chest pain,…  
  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.